Abstract
Treatment of super-refractory status epilepticus: the sooner the better with less adverse effects.
Highlights
Efficacy and Safety of Ketamine in Refractory Status Epilepticus
The state of the literature regarding the treatment [2] and outcome [3] of refractory convulsive status epilepticus (RSE)/super-refractory SE’ (SRSE) has been recently summarized in comprehensive reviews in which it is noted that SRSE occurs in approximately 15% of adults
It was documented that the vast majority of reported cases of SRSE (920/1171, 79%) were treated with pentobarbital, midazolam, or propofol
Summary
Efficacy and Safety of Ketamine in Refractory Status Epilepticus. Rosati A, L’Erario M, Ilvento L, Cecchi C, Pisano T, Mirabile L, Guerrini R. The state of the literature regarding the treatment [2] and outcome [3] of RSE/SRSE has been recently summarized in comprehensive reviews in which it is noted that SRSE occurs in approximately 15% of adults. It was documented that the vast majority of reported cases of SRSE (920/1171, 79%) were treated with pentobarbital, midazolam, or propofol.
Sign-in/Register to view highlights & summary 
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call